Study aims to uncover hidden health differences in rare lung infections
NCT ID NCT07192705
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at 80 adults—40 with NTM lung disease (not on antibiotics) and 40 with bronchiectasis alone—to see if their health needs differ. Using questionnaires and simple physical tests, researchers will assess quality of life, nutrition, mood, and muscle strength. The goal is to better understand what non-drug support (like exercise or diet advice) might help each group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal specific health needs of people with NTM lung disease, leading to better non-drug treatments like exercise or nutrition support.
- What could go wrong
- This is a small, observational study at one center, so results may not apply to everyone. It does not test any treatment, so it won't directly improve health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Free London NHS Foundation Trust
RECRUITINGLondon, NW3 2QG, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gum treatment may lower lung flare-ups in bronchiectasis patients
- Can a daily pill cut dangerous lung Flare-Ups in bronchiectasis?
- Lung inflammation may speed heart aging, study investigates
- Scientists track hidden threat of antibiotic resistance in lung patients
- Handheld breath test could spot lung disease early
- Sauna therapy could slash antibiotic use in chronic lung disease